Yip PK, Bremang M, Pike I, Ponnusamy V, Michael-Titus AT and Shah DK (2023). Newborns with Favourable Outcomes after Perinatal Asphyxia Have Upregulated Glucose Metabolism-Related Proteins in Plasma. Biomolecules  vol. 13, (10) 10.3390/biom13101471

Dyall SC, Nessel I, Sharpe JA, Yip PK, Michael-Titus AT and Shah DK (2023). Long-chain omega-3 polyunsaturated fatty acids are reduced in neonates with substantial brain injury undergoing therapeutic hypothermia after hypoxic–ischemic encephalopathy. Frontiers in Neurology  vol. 14, 10.3389/fneur.2023.1231743

Perez-Ternero C, Pallier PN, Tremoleda JL, Delogu A, Fernandes C, Michael-Titus AT and Hobbs AJ (2022). C-type natriuretic peptide preserves central neurological function by maintaining blood-brain barrier integrity. Frontiers in Molecular Neuroscience  vol. 15, 10.3389/fnmol.2022.991112

Thau-Zuchman O, Pallier PN, Savelkoul PJM, Kuipers AAM, Verkuyl JM and Michael-Titus AT (2022). High phenylalanine concentrations induce demyelination and microglial activation in mouse cerebellar organotypic slices. Frontiers in Neuroscience  vol. 16, 10.3389/fnins.2022.926023

Gala AAD, Kumar H, Sedani S, Openshaw-Lawrence N, Verkuijl JM, Glogowski N, Steingold A, Ponnusamy V, Ekitzidou G, Yip P, Nessel I, Michael-Titus AT, Roeselers G and Shah DK (2022). Alterations in the Stool Microbiome in Newborns Undergoing Mild Therapeutic Hypothermia after Hypoxic-Ischemic Encephalopathy. Developmental Neuroscience  vol. 44, (4-5) 373-383. 10.1159/000522523

Pradelli L, Adolph M, Calder PC, Deutz NE, Carmona TG, Michael-Titus AT, Muscaritoli M and Singer P (2022). Commentary on “Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition”. Journal of Parenteral and Enteral Nutrition  vol. 46, (6) 1226-1227. 10.1002/jpen.2417

Teoh L, Ihalage AA, Harp S, Al-Khateeb ZF, Michael-Titus AT, Tremoleda JL and Hao Y (2022). Deep learning for behaviour classification in a preclinical brain injury model. Plos One  vol. 17, (6 June) 10.1371/journal.pone.0268962

France G, Volianskis R, Ingram R, Bannister N, Rothärmel R, Irvine MW, Fang G, Burnell ES, Sapkota K, Costa BM, Chopra DA, Dravid SM, Michael-Titus AT, Monaghan DT, Georgiou J, Bortolotto ZA, Jane DE, Collingridge GL and Volianskis A (2022). Differential regulation of STP, LTP and LTD by structurally diverse NMDA receptor subunit-specific positive allosteric modulators. Neuropharmacology  vol. 202, 10.1016/j.neuropharm.2021.108840

Brandt MJV, Nijboer CH, Nessel I, Mutshiya TR, Michael‐titus AT, Counotte DS, Schipper L, van der Aa NE, Benders MJNL and de Theije CGM (2022). Nutritional supplementation reduces lesion size and neuroinflammation in a sex‐dependent manner in a mouse model of perinatal hypoxic‐ischemic brain injury. Nutrients  vol. 14, (1) 10.3390/nu14010176

Guesne S, Connole L, Kim S, Motevalli M, Robson L, Michael-Titus AT and Sullivan A (2021). Umbelliferyloxymethyl phosphonate compounds-weakly binding zinc ionophores with neuroprotective properties. Dalton Transactions  vol. 50, (46) 17041-17051. 10.1039/d1dt02298a

Ponnusamy V, Ip RTH, Mohamed MAEK, Clarke P, Wozniak E, Mein C, Schwendimann L, Barlas A, Chisholm P, Chakkarapani E, Michael-Titus AT, Gressens P, Yip PK and Shah DK (2021). Neuronal let-7b-5p acts through the Hippo-YAP pathway in neonatal encephalopathy. Communications Biology  vol. 4, (1) 10.1038/s42003-021-02672-3

Nixon R, Ip THR, Jenkins B, Yip PK, Clarke P, Ponnusamy V, Michael-Titus AT, Koulman A and Shah DK (2021). Lipid profiles from dried blood spots reveal lipidomic signatures of newborns undergoing mild therapeutic hypothermia after hypoxic-ischemic encephalopathy. Nutrients  vol. 13, (12) 10.3390/nu13124301

Baumard L, Weerts ZZRM, Masclee AAM, Keszthelyi D, Michael-Titus AT and Peiris M (2021). Effect of obesity on the expression of nutrient receptors and satiety hormones in the human colon. Nutrients  vol. 13, (4) 10.3390/nu13041271

Gaviria M, Celeghin A, Michael-Titus AT and Pallier PN (2020). Editorial: Brain Plasticity and Contribution of the Emotional Brain to Neural Remodelling After Injury. Frontiers Media  Frontiers in Neurology  vol. 11, 606271-606271. 10.3389/fneur.2020.606271

Shah DK, Yip PK, Barlas A, Tharmapoopathy P, Ponnusamy V, Michael-Titus AT and Chisholm P (2020). Raised Plasma Neurofilament Light Protein Levels After Rewarming Are Associated With Adverse Neurodevelopmental Outcomes in Newborns After Therapeutic Hypothermia. Frontiers in Neurology  vol. 11, 10.3389/fneur.2020.562510

Nessel I and Michael-Titus AT (2020). Lipid profiling of brain tissue and blood after traumatic brain injury: A review of human and experimental studies. Seminars in Cell and Developmental Biology  10.1016/j.semcdb.2020.08.004

Zirpoli H, Chang CL, Carpentier YA, Michael-Titus AT, Ten VS and Deckelbaum RJ (2020). Novel Approaches for Omega-3 Fatty Acid Therapeutics: Chronic Versus Acute Administration to Protect Heart, Brain, and Spinal Cord. Annual Review of Nutrition  vol. 40, 161-187. 10.1146/annurev-nutr-082018-124539

Vrettos EI, Valverde IE, Mascarin A, Pallier PN, Cerofolini L, Fragai M, Parigi G, Hirmiz B, Bekas N, Grob NM, Stylos EΚ, Shaye H, Del Borgo M, Aguilar M, Magnani F, Syed N, Crook T, Waqif E, Ghazaly E, Cherezov V, Widdop RE, Luchinat C, Michael‐Titus AT, Mindt TL and Tzakos AG (2020). Cover Feature: Single Peptide Backbone Surrogate Mutations to Regulate Angiotensin GPCR Subtype Selectivity (Chem. Eur. J. 47/2020). Wiley  Chemistry - a European Journal  vol. 26, (47) 10646-10646. 10.1002/chem.202003569

Vrettos EI, Valverde IE, Mascarin A, Pallier PN, Cerofolini L, Fragai M, Parigi G, Hirmiz B, Bekas N, Grob NM, Stylos E, Shaye H, Del Borgo M, Aguilar M-I, Magnani F, Syed N, Crook T, Waqif E, Ghazaly E, Cherezov V, Widdop RE, Luchinat C, Michael-Titus AT, Mindt TL and Tzakos A (2020). Single peptide backbone surrogate mutations to regulate angiotensin GPCR subtype selectivity. Wiley  Chemistry: a European Journal  10.1002/chem.202000924

Yip PK, Schmitzberger M, Al-Hasan M, George J, Tripoliti E, Michael-Titus AT, Clayton D and Priestley JV (2020). Serotonin expression in the song circuitry of adult male zebra finches. Neuroscience  10.1016/j.neuroscience.2020.06.018

Lilley E, Andrews MR, Bradbury EJ, Elliott H, Hawkins P, Ichiyama RM, Keeley J, Michael-Titus AT, Moon LDF, Pluchino S, Riddell J, Ryder K and Yip PK (2020). Refining rodent models of spinal cord injury. Elsevier  Experimental Neurology  vol. 328, 10.1016/j.expneurol.2020.113273

Thau-Zuchman O, Ingram R, Harvey GG, Cooke T, Palmas F, Pallier PN, Brook J, Priestley JV, Dalli J, Tremoleda JL and Michael-Titus AT (2020). A single injection of docosahexaenoic acid induces a pro-resolving lipid mediator profile in the injured tissue and a long-lasting reduction in neurological deficit after traumatic brain injury in mice. Journal of Neurotrauma  vol. 37, (1) 66-79. 10.1089/neu.2019.6420

Thau-Zuchman O, Svendsen L, Dyall SC, Paredes-Esquivel U, Rhodes M, Priestley JV, Feichtinger RG, Kofler B, Lotstra S, Martin Verkuyl J, Hageman RJ, Broersen LM, van Wijk N, Silva JP, Tremoleda JL and Michael-Titus AT (2020). A new ketogenic formulation improves functional outcome and reduces tissue loss following traumatic brain injury in adult mice. Theranostics  vol. 11, (1) 346-360. 10.7150/thno.48995

Yip PK, Bowes AL, Hall JCE, Burguillos MA, Richard Ip TH, Baskerville T, Liu ZH, Mohamed MAEK, Getachew F, Lindsay AD, Najeeb SUR, Popovich PG, Priestley JV and Michael-Titus AT (2019). Docosahexaenoic acid reduces microglia phagocytic activity via miR-124 and induces neuroprotection in rodent models of spinal cord contusion injury. Human Molecular Genetics  vol. 28, (14) 2427-2448. 10.1093/hmg/ddz073

Yip PK, Chapman GE, Sillito RR, Ip THR, Akhigbe G, Becker SC, Price AW, Michael-Titus AT, Armstrong JD and Tremoleda JL (2019). Studies on long term behavioural changes in group-housed rat models of brain and spinal cord injury using an automated home cage recording system. Journal of Neuroscience Methods  vol. 321, 49-63. 10.1016/j.jneumeth.2019.04.005

Thau-Zuchman O, Gomes RN, Dyall SC, Davies M, Priestley JV, Groenendijk M, De Wilde MC, Tremoleda JL and Michael-Titus AT (2019). Brain Phospholipid Precursors Administered Post-Injury Reduce Tissue Damage and Improve Neurological Outcome in Experimental Traumatic Brain Injury. Journal of Neurotrauma  vol. 36, (1) 25-42. 10.1089/neu.2017.5579

Adolph M, Calder PC, Deutz NE, Carmona TG, Klek S, Lev S, Mayer K, Michael-Titus AT, Pradelli L, Puder M, Singer P and Vlaardingerbroek H (2018). Commentary on Fish Oil-Containing Lipid Emulsions in Adult Parenteral Nutrition: A Review of the Evidence (https://doi.org/10.1177/0148607117721907). Jpen J Parenter Enteral Nutr  10.1002/jpen.1047

Shah DK, Ponnusamy V, Evanson J, Kapellou O, Ekitzidou G, Gupta N, Clarke P, Michael-Titus AT and Yip PK (2018). Raised plasma neurofilament light protein levels are associated with abnormal MRI outcomes in newborns undergoing therapeutic hypothermia. Frontiers in Neurology  vol. 9, (MAR) 10.3389/fneur.2018.00086

Calder PC, Adolph M, Deutz NE, Grau T, Innes JK, Klek S, Lev S, Mayer K, Michael-Titus AT, Pradelli L, Puder M, Vlaardingerbroek H and Singer P (2018). Lipids in the intensive care unit: Recommendations from the ESPEN Expert Group. Clinical Nutrition  vol. 37, (1) 1-18. 10.1016/j.clnu.2017.08.032

Lopez-Tremoleda J, Alvarez K, ADEN A, DONNAN RS, MICHAEL-TITUS AT and TOMLINS PH (2017). Heart-rate sensitive optical coherence angiography for measuring vascular changes due to posttraumatic brain injury in mice. Society of Photo-Optical Instrumentation Engineers  Journal of Biomedical Optics  vol. 22, (12) 121710-121710. 10.1117/1.JBO.22.12.121710

Lee WLA, Michael-Titus AT and Shah DK (2017). Hypoxic-Ischaemic Encephalopathy and the Blood-Brain Barrier in Neonates. Developmental Neuroscience  vol. 39, (1-4) 49-58. 10.1159/000467392

Yip PK, Carrillo-Jimenez A, King P, Vilalta A, Nomura K, Chau CC, Egerton AMS, Liu Z-H, Shetty AJ, Tremoleda JL, Davies M, Deierborg T, Priestley JV, Brown GC, Michael-Titus AT, Venero JL and Burguillos MA (2017). Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration. Nature Publishing Group  Scientific Reports  vol. 7, 41689-41689. 10.1038/srep41689

Liu Z-H, Yip PK, Priestley JV and Michael-Titus AT (2017). A Single Dose of Docosahexaenoic Acid Increases the Functional Recovery Promoted by Rehabilitation after Cervical Spinal Cord Injury in the Rat. J Neurotrauma  vol. 34, (9) 1766-1777. 10.1089/neu.2016.4556

Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Vadivelu KC, Yip PK, Sosabowski J, Trigg W and Michael-Titus AT (2016). In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [18F]GE-180 and effect of docosahexaenoic acid. European Journal of Nuclear Medicine and Molecular Imaging  10.1007/s00259-016-3391-8

Ponnusamy V, Kapellou O, Yip E, Evanson J, Wong LF, Michael-Titus A, Yip PK and Shah DK (2016). A study of microRNAs from dried blood spots in newborns after perinatal asphyxia: A simple and feasible biosampling method. Pediatric Research  vol. 79, (5) 799-805. 10.1038/pr.2015.276

Thau-Zuchman O, Pallier PN, Davies M, Groenendijk M, de Wilde MC, Tremoleda JL and Michael-Titus AT (2016). A specific multi-nutrient intervention, designed to enhance synapse formation and function, improves functional outcome following traumatic brain injury. Brain Injury  vol. 30, (5-6) 679-679.

Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Trigg W, Sosabowski J, Mather SJ and Michael-Titus A (2015). T-14: IN VIVO IMAGING OF NEUROINFLAMMATION IN NEUROTRAUMA PRECLINICAL MODELS: POTENTIAL FOR CLINICAL TRANSLATION. Shock  vol. 44 Suppl 2, 24-25. 10.1097/01.shk.0000472079.77136.27

Liu ZH, Yip PK, Adams L, Davies M, Lee JW, Michael GJ, Priestley JV and Michael-Titus AT (2015). A single bolus of docosahexaenoic acid promotes neuroplastic changes in the innervation of spinal cord interneurons and motor neurons and improves functional recovery after spinal cord injury. Journal of Neuroscience  vol. 35, (37) 12733-12752. 10.1523/JNEUROSCI.0605-15.2015

Pallier PN, Poddighe L, Zbarsky V, Kostusiak M, Choudhury R, Hart T, Burguillos MA, Musbahi O, Groenendijk M, Sijben JW, deWilde MC, Quartu M, Priestley JV and Michael-Titus AT (2015). A nutrient combination designed to enhance synapse formation and function improves outcome in experimental spinal cord injury. Neurobiology of Disease  vol. 82, 504-515. 10.1016/j.nbd.2015.09.007

Ward RE, Huang W, Kostusiak M, Pallier PN, Michael-Titus AT and Priestley JV (2014). A characterization of white matter pathology following spinal cord compression injury in the rat. Neuroscience  vol. 260, 227-239. 10.1016/j.neuroscience.2013.12.024

Paterniti I, Impellizzeri D, Di Paola R, Esposito E, Gladman S, Yip P, Priestley JV, Michael-Titus AT and Cuzzocrea S (2014). Docosahexaenoic acid attenuates the early inflammatory response following spinal cord injury in mice: in-vivo and in-vitro studies. J Neuroinflammation  vol. 11, 10.1186/1742-2094-11-6

Michael-Titus AT and Priestley JV (2014). Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity? Trends Neurosci  vol. 37, (1) 30-38. 10.1016/j.tins.2013.10.005

Nikolakopoulou Z, Nteliopoulos G, Michael-Titus AT and Parkinson EK (2013). Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2. Carcinogenesis  vol. 34, (12) 2716-2725. 10.1093/carcin/bgt257

Nikolakopoulou Z, Shaikh MH, Dehlawi H, Michael-Titus AT and Parkinson EK (2013). The induction of apoptosis in pre-malignant keratinocytes by omega-3 polyunsaturated fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) is inhibited by albumin. Toxicol Lett  vol. 218, (2) 150-158. 10.1016/j.toxlet.2013.01.021

Lim S-N, Gladman SJ, Dyall SC, Patel U, Virani N, Kang JX, Priestley JV and Michael-Titus AT (2013). Transgenic mice with high endogenous omega-3 fatty acids are protected from spinal cord injury. Neurobiol Dis  vol. 51, 104-112. 10.1016/j.nbd.2012.10.021

Lim S-N, Huang W, Hall JCE, Michael-Titus AT and Priestley JV (2013). Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid. Exp Neurol  vol. 239, 13-27. 10.1016/j.expneurol.2012.09.015

Yip PK, Pizzasegola C, Gladman S, Biggio ML, Marino M, Jayasinghe M, Ullah F, Dyall SC, Malaspina A, Bendotti C and Michael-Titus A (2013). The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis. Plos One  vol. 8, (4) 10.1371/journal.pone.0061626

Hall JCE, Priestley JV, Perry VH and Michael-Titus AT (2012). Docosahexaenoic acid, but not eicosapentaenoic acid, reduces the early inflammatory response following compression spinal cord injury in the rat. J Neurochem  vol. 121, (5) 738-750. 10.1111/j.1471-4159.2012.07726.x

Gladman SJ, Huang W, Lim S-N, Dyall SC, Boddy S, Kang JX, Knight MM, Priestley JV and Michael-Titus AT (2012). Improved outcome after peripheral nerve injury in mice with increased levels of endogenous ω-3 polyunsaturated fatty acids. J Neurosci  vol. 32, (2) 563-571. 10.1523/JNEUROSCI.3371-11.2012

Priestley JV, Michael-Titus AT and Tetzlaff W (2012). Limiting spinal cord injury by pharmacological intervention. Handb Clin Neurol  vol. 109, 463-484. 10.1016/B978-0-444-52137-8.00029-2

Gladman S, Lim SN, Dyall S, Knight MM, Priestley JV and Michael-Titus AT (2011). Omega-3 fatty acids and acute neurological trauma: A perspective on clinical translation. Ocl - Oleagineux Corps Gras Lipides  vol. 18, (6) 317-323. 10.1684/ocl.2011.0421

Zbarsky-Barquero⁎ V, Sijben J, De Wilde M, Priestley JV and Michael-Titus AT (2011). A multi-nutrient composition with neuroprotective properties in spinal cord injury. Elsevier  European Journal of Pharmacology  vol. 668, e10-e11. 10.1016/j.ejphar.2011.09.217

Gladman SJ, Ward RE, Michael-Titus AT, Knight MM and Priestley JV (2010). The effect of mechanical strain or hypoxia on cell death in subpopulations of rat dorsal root ganglion neurons in vitro. Neuroscience  vol. 171, (2) 577-587. 10.1016/j.neuroscience.2010.07.009

Jokic N, Yip PK, Michael-Titus A, Priestley JV and Malaspina A (2010). The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compression. Springer  Bmc Genomics  vol. 11, 633-633. 10.1186/1471-2164-11-633

Ward RE, Huang W, Curran OE, Priestley JV and Michael-Titus AT (2010). Docosahexaenoic acid prevents white matter damage after spinal cord injury. J Neurotrauma  vol. 27, (10) 1769-1780. 10.1089/neu.2010.1348

Malaspina A, Ngoh SFA, Ward RE, Hall JCE, Tai FWD, Yip PK, Jones C, Jokic N, Averill SA, Michael-Titus AT and Priestley JV (2010). Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis. Neuroscience  vol. 169, (2) 812-827. 10.1016/j.neuroscience.2010.04.053

Dyall SC, Michael GJ and Michael-Titus AT (2010). Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. J Neurosci Res  vol. 88, (10) 2091-2102. 10.1002/jnr.22390

Robson LG, Dyall SC, Sidloff D and Michael-Titus AT (2010). Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. Neurobiol Aging  vol. 31, (4) 678-687. 10.1016/j.neurobiolaging.2008.05.027

Kiasalari Z, Salehi I, Zhong Y, McMahon SB, Michael-Titus AT and Michael GJ (2010). Identification of Perineal Sensory Neurons Activated by Innocuous Heat. J Comp Neurol  vol. 518, (2) 137-162. 10.1002/cne.22187

Michael-Titus A, Revest P and Shortland P (2010). 6 CRANIAL NERVES AND THE BRAINSTEM. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00006-x

Michael-Titus A, Revest P and Shortland P (2010). 7 THE VISUAL SYSTEM. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00007-1

Michael-Titus A, Revest P and Shortland P (2010). 8 HEARING AND BALANCE THE AUDITORY AND VESTIBULAR SYSTEMS. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00008-3

Michael-Titus A, Revest P and Shortland P (2010). 3 CLINICAL EXAMINATION. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00003-4

Michael-Titus A, Revest P and Shortland P (2010). 13 EPILEPSY. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00013-7

Michael-Titus A, Revest P and Shortland P (2010). 5 PAIN AND ANALGESIA. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00005-8

Michael-Titus A, Revest P and Shortland P (2010). 17 ADDICTION. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00017-4

Michael-Titus A, Revest P and Shortland P (2010). 10 MOTOR SYSTEMS II THE BASAL GANGLIA. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00010-1

Michael-Titus A, Revest P and Shortland P (2010). 16 DEPRESSION AND ANXIETY. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00016-2

Michael-Titus A, Revest P and Shortland P (2010). 15 SCHIZOPHRENIA. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00015-0

Michael-Titus A, Revest P and Shortland P (2010). 14 DEMENTIA. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00014-9

Michael-Titus A, Revest P and Shortland P (2010). 4 THE SPINAL CORD. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00004-6

Michael-Titus A, Revest P and Shortland P (2010). 12 INFECTION IN THE CENTRAL NERVOUS SYSTEM. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00012-5

Michael-Titus A, Revest P and Shortland P (2010). 1 ORGANIZATION OF THE NERVOUS SYSTEM. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00001-0

Michael-Titus A, Revest P and Shortland P (2010). 11 STROKE AND HEAD INJURY. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00011-3

Michael-Titus A, Revest P and Shortland P (2010). 9 MOTOR SYSTEMS I DESCENDING PATHWAYS AND CEREBELLUM. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00009-5

Michael-Titus A, Revest P and Shortland P (2010). 2 ELEMENTS OF CELLULAR AND MOLECULAR NEUROSCIENCE. The Nervous System  Elsevier  10.1016/b978-0-7020-3373-5.00002-2

Michael-Titus A, Revest P and Shortland P (2010). The Nervous System: Systems of the Body Series.

Lim S-N, Huang W, Hall JCE, Ward RE, Priestley JV and Michael-Titus AT (2010). The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats. Prostaglandins Leukot Essent Fatty Acids  vol. 83, (4-6) 193-201. 10.1016/j.plefa.2010.08.003

Wann AKT, Mistry J, Blain EJ, Michael-Titus AT and Knight MM (2010). Eicosapentaenoic acid and docosahexaenoic acid reduce interleukin-1β-mediated cartilage degradation. Arthritis Res Ther  vol. 12, (6) 10.1186/ar3183

Huang W, Bhavsar A, Ward RE, Hall JCE, Priestley JV and Michael-Titus AT (2009). Arachidonyl trifluoromethyl ketone is neuroprotective after spinal cord injury. J Neurotrauma  vol. 26, (8) 1429-1434. 10.1089/neu.2008.0835

Huang WL, Bhavsar A, Ward RE, Hall JCE, Priestley JV and Michael-Titus AT (2009). Arachidonyl Trifluoromethyl Ketone Is Neuroprotective after Spinal Cord Injury. J Neurotraum  vol. 26, (8) 1429-1434. 10.1089/neu.2008.0835

Michael-Titus AT (2009). Omega-3 fatty acids: their neuroprotective and regenerative potential in traumatic neurological injury. Clin Lipidol  vol. 4, (3) 343-353. 10.2217/CLP.09.19

Michael-Titus AT, Albert M, Michael GJ, Michaelis T, Watanabe T, Frahm J, Pudovkina O, van der Hart MGC, Hesselink MB, Fuchs E and Czéh B (2008). SONU20176289, a compound combining partial dopamine D(2) receptor agonism with specific serotonin reuptake inhibitor activity, affects neuroplasticity in an animal model for depression. Eur J Pharmacol  vol. 598, (1-3) 43-50. 10.1016/j.ejphar.2008.09.006

Malaspina A and Michael-Titus AT (2008). Is the modulation of retinoid and retinoid-associated signaling a future therapeutic strategy in neurological trauma and neurodegeneration? J Neurochem  vol. 104, (3) 584-595. 10.1111/j.1471-4159.2007.05071.x

Dyall SC and Michael-Titus AT (2008). Neurological Benefits of Omega-3 Fatty Acids. Neuromol Med  vol. 10, (4) 219-235. 10.1007/s12017-008-8036-z

Jokic N, Ling YY, Ward RE, Michael-Titus AT, Priestley JV and Malaspina A (2007). Retinoid receptors in chronic degeneration of the spinal cord: observations in a rat model of amyotrophic lateral sclerosis. J Neurochem  vol. 103, (5) 1821-1833. 10.1111/j.1471-4159.2007.04893.x

Huang WL, King VR, Curran OE, Dyall SC, Ward RE, Lal N, Priestley JV and Michael-Titus AT (2007). A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain  vol. 130, (Pt 11) 3004-3019. 10.1093/brain/awm223

King VR, Averill SA, Hewazy D, Priestley JV, Torup L and Michael-Titus AT (2007). Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur J Neurosci  vol. 26, (1) 90-100. 10.1111/j.1460-9568.2007.05635.x

Dyall SC, Michael GJ, Whelpton R, Scott AG and Michael-Titus AT (2007). Dietary enrichment with omega-3 polyunsaturated fatty acids reverses age-related decreases in the GluR2 and NR2B glutamate receptor subunits in rat forebrain. Neurobiol Aging  vol. 28, (3) 424-439. 10.1016/j.neurobiolaging.2006.01.002

Ward RE, Huang W, Hall JCE, Priestley JV and Michael-Titus AT (2007). Effect of docosahexaenoic acid on axonal damage after spinal cord injury. Ocl - Oleagineux Corps Gras Lipides  vol. 14, (3-4) 10.1051/ocl.2007.0234

Michael-Titus AT (2007). Omega-3 fatty acids and neurological injury. Prostaglandins Leukot Essent Fatty Acids  vol. 77, (5-6) 295-300. 10.1016/j.plefa.2007.10.021

Makwana M, Raivich G, Dyall S and Michael-Titus A (2007). Effect of docosahexaenoic acid in a mouse facial nerve injury model. Ocl - Oleagineux Corps Gras Lipides  vol. 14, (3-4) 10.1051/ocl.2007.0233

Dyall SC, Michael GJ and Michael-Titus AT (2007). Omega-3 polyunsaturated fatty acids reverse age-related decreases in retinoic acid receptors, retinoid x receptors and peroxisome-proliferator-activated receptors in rat forebrain. Ocl - Oleagineux Corps Gras Lipides  vol. 14, (3-4) 10.1051/ocl.2007.0232

King VR, Huang WL, Dyall SC, Curran OE, Priestley JV and Michael-Titus AT (2006). Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci  vol. 26, (17) 4672-4680. 10.1523/JNEUROSCI.5539-05.2006

Penschuck S, Flagstad P, Didriksen M, Leist M and Michael-Titus AT (2006). Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia. Eur J Neurosci  vol. 23, (1) 279-284. 10.1111/j.1460-9568.2005.04536.x

Flagstad P, Mørk A, Glenthøj BY, van Beek J, Michael-Titus AT and Didriksen M (2004). Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens. Neuropsychopharmacology  vol. 29, (11) 2052-2064. 10.1038/sj.npp.1300516

Nazir S, Michael GJ and Michael-Titus AT (2002). Distribution of NMDA and AMPA glutamate receptor subunits in rat prefrontal cortex and the effect of chronic imipramine treatment on the GluR2 subunit. Brit J Pharmacol  vol. 135,

Hawkins A, McCune L, Whelpton R and Michael-Titus AT (2002). Effect of noradrenaline and 5-HT on excitatory amino acid release in rat prefrontal cortex. Brit J Pharmacol  vol. 135,

Michael-Titus AT, Fernandes K, Setty H and Whelpton R (2002). In vivo metabolism and clearance of substance P and co-expressed tachykinins in rat striatum. Neuroscience  vol. 110, (2) 277-286. 10.1016/s0306-4522(01)00530-9

Toner CC, Connell K, Whelpton R, Bains S, Michael-Titus AT, McLaughlin DP and Stamford JA (2001). Effects of sevoflurane on dopamine, glutamate and aspartate release in an in vitro model of cerebral ischaemia. Brit J Anaesth  vol. 86, (4) 550-554. 10.1093/bja/86.4.550

Khan S, Whelpton R and Michael-Titus AT (2000). Substance P modulation of striatal dopamine outflow is determined by M1 and M2 muscarinic receptors in male Wistar rats. Neuroscience Letters  vol. 293, (3) 179-182. 10.1016/S0304-3940(00)01529-9

Michael-Titus AT, Bains S, Jeetle J and Whelpton R (2000). Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex - A possible mechanism of neuroprotection in major depression? Neuroscience  vol. 100, (4) 681-684. 10.1016/S0306-4522(00)00390-0

Michael-Titus AT, Blackburn D, Connolly Y, Priestley JV and Whelpton R (1999). N-and C-terminal substance P fragments: Differential effects on striatal [³H]substance P binding and NK1 receptor internalization. Neuroreport  vol. 10, (10) 2209-2213. 10.1097/00001756-199907130-00038

Whelpton R, Michael-Titus AT, Stephens SM, Yau KW and Fengas D (1998). Identification of substance P metabolites using a combination of reversed-phase high-performance liquid chromatography and capillary electrophoresis. Journal of Chromatography B: Biomedical Applications  vol. 716, (1-2) 95-106. 10.1016/S0378-4347(98)00334-X

Khan S, Sandhu J, Whelpton R and Michael-Titus AT (1998). Substance P fragments and striatal endogenous dopamine outflow: Interaction with substance P. Neuropeptides  vol. 32, (6) 519-526. 10.1016/S0143-4179(98)90080-4

MichaelTitus AT, Whelpton R, Stephens SM and Yau KW (1997). Metabolism of substance P in rat striatum studies using a combination of high performance liquid chromatography (HPLC) and capillary electrophoresis (CE). Brit J Pharmacol  vol. 122, P79-P79.

Khan S, Sandhu J, Whelpton R and MichaelTitus AT (1996). Substance fragments, SP1-9 and SP6-11, modulate endogenous dopamine outflow in rat striatum. Brit J Pharmacol  vol. 119, P175-P175.

Khan S, Whelpton R and Michael-Titus AT (1996). Evidence for modulatory effects of substance P fragments (1-4) and (8-11) on endogenous dopamine outflow in rat striatal slices. Neuroscience Letters  vol. 205, (1) 33-36. 10.1016/0304-3940(96)12363-6

Whelpton R, Michael-Titus AT, Jamdar RP, Abdillahi K and Grahn MF (1996). Distribution and excretion of radiolabeled temoporfin in a murine tumor model. Photochemistry and Photobiology  vol. 63, (6) 885-891. 10.1111/j.1751-1097.1996.tb09646.x

Khan S, Grogan E, Whelpton R and Michael-Titus AT (1996). N- and C-terminal substance P fragments modulate striatal dopamine outflow through a cholinergic link mediated by muscarinic receptors. Neuroscience  vol. 73, (4) 919-927. 10.1016/0306-4522(96)00119-4

KHAN S, GROGAN E, WHELPTON R and MICHAELTITUS AT (1995). SUBSTANCE-P AND ITS FRAGMENT-(1-7) AND FRAGMENT-(5-11) MODULATE STRIATAL DOPAMINE OUTFLOW VIA A CHOLINERGIC LINK MEDIATED BY MUSCARINIC RECEPTORS. Brit J Pharmacol  vol. 116, P96-P96.

Khan S, Brooks N, Whelpton R and Michael-Titus AT (1995). Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum. European Journal of Pharmacology  vol. 282, (1-3) 229-233. 10.1016/0014-2999(95)00342-I

KHAN S, WHELPTON R and MICHAEL-TITUS A (1995). ENDOGENOUS DOPAMINE OUTFLOW FROM RAT STRIATAL SLICES IN STATIC AND DYNAMIC CONDITIONS. Neurosci Res Commun  vol. 16, (3) 145-153.

WHELPTON R, MICHAELTITUS AT and YAQUB Z (1995). TEMOPORFIN BINDING TO HUMAN SERUM-LIPOPROTEINS. Brit J Pharmacol  vol. 114, P265-P265.

IRAVANI MM, KHAN S, MICHAELTITUS A, WHELPTON R and KRUK ZL (1995). EFFECTS OF 6-HYDROXYDOPAMINE LESIONS IN THE VENTRAL TEGMENTAL AREA OR SUBSTANTIA-NIGRA ON DOPAMINE RELEASE IN SUBREGIONS OF THE RAT STRIATUM. Brit J Pharmacol  vol. 114, P337-P337.

Whelpton R, Michael‐Titus AT, Basra SS and Grahn M (1995). DISTRIBUTION OF TEMOPORFIN, A NEW PHOTOSENSITIZER FOR THE PHOTODYNAMIC THERAPY OF CANCER, IN A MURINE TUMOR MODEL. Photochemistry and Photobiology  vol. 61, (4) 397-401. 10.1111/j.1751-1097.1995.tb08629.x

Michael‐Titus A, Whelpton R and Yaqub Z (1995). Binding of temoporfin to the lipoprotein fractions of human serum. British Journal of Clinical Pharmacology  vol. 40, (6) 594-597. 10.1111/j.1365-2125.1995.tb05805.x

Das D, Rogers J and Michael-Titus AT (1994). Comparative study of the effects of mu, delta and kappa opioid agonists on 3H-dopamine uptake in rat striatum and nucleus accumbens. Neuropharmacology  vol. 33, (2) 221-226. 10.1016/0028-3908(94)90012-4

Dourmap N, Michael‐Titus A and Costentin J (1992). Differential Effect of Intrastriatal Kainic Acid on the Modulation of Dopamine Release by μ‐ and δ‐Opioid Peptides: A Microdialysis Study. Journal of Neurochemistry  vol. 58, (2) 709-713. 10.1111/j.1471-4159.1992.tb09775.x

Bousselmame R, Michael-Titus A and Costentin J (1991). Desensitization of μ-opioid receptors does not modify the analgesia induced by an enkephalinase inhibitor. European Journal of Pharmacology  vol. 203, (2) 295-297. 10.1016/0014-2999(91)90728-9

Bousselmame R, Eustache M, Michael-Titus A and Costentin J (1991). Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats. Neuropharmacology  vol. 30, (8) 865-870. 10.1016/0028-3908(91)90120-Z

Michael-Titus A, Bousselmame R and Costentin J (1990). Stimulation of dopamine D2 receptors induces an analgesia involving an opiodergic but non enkephalinergic link. European Journal of Pharmacology  vol. 187, (2) 201-207. 10.1016/0014-2999(90)90007-S

Dourmap N, Michael-Titus A and Costentin J (1990). Local enkephalins tonically modulate dopamine release in the striatum: a microdialysis study. Brain Research  vol. 524, (1) 153-155. 10.1016/0006-8993(90)90505-6

Costentin J, Duterte-Boucher D, Panissaud C and Michael-Titus A (1990). Dopamine D1 and D2 receptors mediate opposite effects of apomorphine on the body temperature of reserpinized mice. Neuropharmacology  vol. 29, (1) 31-35. 10.1016/0028-3908(90)90080-B

Dourmap N, Michael‐Titus A and Costentin J (1990). Acetorphan, an Enkephalinase Inhibitor, Modulates Dopaminergic Transmission in Rat Olfactory Tubercle, but not in the Nucleus Accumbens and Striatum. European Journal of Neuroscience  vol. 2, (9) 783-787. 10.1111/j.1460-9568.1990.tb00469.x

Michael-Titus A, Dourmap N, Costentin J and Schwartz JC (1990). Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice. Neuropeptides  vol. 15, (2) 89-100. 10.1016/0143-4179(90)90044-Y

Michael-Titus A, Dourmap N and Costentin J (1989). MU and delta opioid receptors control differently the horizontal and vertical components of locomotor activity in mice. Neuropeptides  vol. 13, (4) 235-242. 10.1016/0143-4179(89)90076-0

Michael-Titus A, Dourmap N, Caline H, Costentin J and Schwartz JC (1989). Role of endogenous enkephalins in locomotion and nociception studied with peptidase inhibitors in two inbred strains of mice (C57BL/6J AND DBA/2J). Neuropharmacology  vol. 28, (2) 117-122. 10.1016/0028-3908(89)90046-4

Duterte-Eoucher D, Panissaud C, Michael-Titus A and Costentin J (1989). Stimulation of central D1 dopamine receptors reverses reserpine-induced hypothermia in mice. Neuropharmacology  vol. 28, (4) 419-421. 10.1016/0028-3908(89)90039-7

Michael-Titus A, Preterre P, Giros B and Costentin J (1987). Role of endogenous enkephalins in locomotion evidenced by acetorphan, an 'enkephalinase' inhibitor. Journal of Pharmacology and Experimental Therapeutics  vol. 243, (3) 1062-1066.

Michael-Titus A and Costentin J (1987). Analgesic effects of metapramine and evidence against the involvement of endogenous enkephalins in the analgesia induced by tricyclic antidepressants. Pain  vol. 31, (3) 391-400. 10.1016/0304-3959(87)90167-9